Technology News and Research

RSS

Menicon opens new contact lens R&D and manufacturing facility in Singapore

Menicon Singapore, a subsidiary of Menicon Co., Ltd., Japan's first and largest contact lens manufacturer, has opened its new R&D and manufacturing facility.

22 Mar 2011

UCSD selects Millennium Labs, Research Institute for NIAAA granted study

Millennium Laboratories, a leading provider of therapeutic drug monitoring, research and healthcare education, and the Millennium Research Institute, a national non-profit research center, announced today they have been selected by the University of California, San Diego School of Medicine to provide laboratory services, including research and analysis, for a new UC San Diego study funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

22 Mar 2011

Objet demonstrates 3D printing solution benefits for digital dentistry at IDS

As digital dentistry becomes a standard production tool for many dental practices and laboratories, Objet Geometries Ltd. demonstrates the benefits of adding 3D printing to the workflow at IDS.

22 Mar 2011

PSN system can reduce psychiatric medication errors

Coupling an electronic prescription drug ordering system with a computerized method for reporting adverse events can dramatically reduce the number of medication errors in a hospital's psychiatric unit, suggests new Johns Hopkins research.

22 Mar 2011

Cordis launches new PTA Balloon Catheter to treat PAD

Cordis Corporation is pleased to announce the launch of SLEEK® OTW Catheter, a new .014" Percutaneous Transluminal Angioplasty Balloon Catheter designed to help physicians save limbs and enhance patients' lives.

22 Mar 2011

CMU's CNAST receives DSF Charitable Foundation grant to develop novel biomedical tools

The DSF Charitable Foundation has given a $3.9 million grant to Carnegie Mellon University's Center for Nucleic Acids Science and Technology to further the development of novel biomedical tools targeted at monitoring and manipulating gene expression.

22 Mar 2011

BDSI's BEMA drug delivery technology receives Canada patent

BioDelivery Sciences International, Inc. announced the issuance of a patent extending the exclusivity of the BioErodible MucoAdhesive drug delivery technology in Canada from 2017 to 2027. The patent was been reviewed by the Office of Patented Medicines for listing in the Canadian Patent Register and was found eligible for listing.

22 Mar 2011

Rxi's new RNAi preclinical data to be presented at Keystone conference

RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.

22 Mar 2011

STJ inaugurates Advanced Technology Center for physicians in Beijing

St. Jude Medical, Inc., a global medical device company, today celebrated the grand opening of the St. Jude Medical Advanced Technology Center Asia Pacific, located in Beijing, China.

22 Mar 2011

City Of Hope opens new center for diabetes research and care

City of Hope has established a new Diabetes Research Center that will expand its pioneering investigations into diabetes, endocrinology and metabolic diseases, create an infrastructure to support translational research and enhance clinical care for diabetes and its related complications.

22 Mar 2011

USPTO grants patent to HistoRx methods for digital microscopy standardization

HistoRx, Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for standardization of digital microscopy instruments in order to go beyond imaging to generating high-quality reproducible data that precisely relates to biomarker concentrations in tissue sections.

22 Mar 2011

Information technology could reduce psychiatric drug errors

21 Mar 2011

Earthquake response could be improved through telemedicine

A new study published by researchers at Weill Cornell Medical College and the University of California, Davis, foresees improvements in patient outcomes after a major earthquake through more effective use of information technology. A control tower-style telemedicine hub to manage electronic traffic between first responders and remote medical experts could boost the likelihood that critically injured victims will get timely care and survive, according to the team's computer simulation model.

21 Mar 2011

Second US trial in HIV/AIDS lymphoma patients using Benitec’s ddRNAi technology

Benitec Limited (ASX:BLT), a company involved in RNA-based gene silencing for human therapeutics, announced that the City of Hope research hospital in Duarte, California is planning to initiate a second small Phase I/II study using Benitec’s DNA-directed RNA interference (ddRNAi) technology in lymphoma patients carrying the HIV virus. The aim of the study is to optimize the treatment by modifying a range of clinical parameters.

21 Mar 2011

ADDF awards ADispell 170,750 grant to develop drugs against Alzheimer's Disease

The Alzheimer's Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $170,750 to ADispell Inc. to develop small molecule drugs designed to halt the progression of cognition loss that occurs with Alzheimer's Disease.

21 Mar 2011

Svelte Medical completes 6 month follow up in initial Acrobat angioplasty system clinical trial

Svelte™ Medical Systems, Inc. is pleased to announce that it has completed 6 month follow up in its initial clinical trial with the Svelte Acrobat angioplasty system.

21 Mar 2011

Sarsia Seed provides follow-up funding for APIM Therapeutics

APIM Therapeutics AS, an early-stage Norwegian therapeutic company, is pursuing a novel drug approach with the ability to potentiate the action of a wide range of chemotherapeutic drugs currently used to treat several types of cancer.

21 Mar 2011

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

A physician affiliated with Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital (SLEH) is the first in Houston and among the first in the nation to treat patients for an irregular heartbeat with a new, minimally invasive cryoballoon technology that uses cold rather than heat to interrupt faulty electrical circuits in the heart.

21 Mar 2011

CardioFocus secures $5M in debt financing from Silicon Valley Bank

CardioFocus, a venture capital-backed medical device company developing technology to treat cardiac disorders, has secured $5M in debt financing from Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide. CardioFocus will use the new financing to initiate its pivotal trial in the United States and to expand the commercialization of its products in Europe.

21 Mar 2011

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

NasVax announces the success of a Phase 2a clinical trial of a new oral immunotherapy for non-alcoholic steatohepatitis (NASH), an inflammatory disease associated with fatty liver disease and the metabolic syndrome.

21 Mar 2011